Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Plos Medicine|May 16, 2018
Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trialIngvild Vik, Marianne Bollestad, Nils Grude, et al.
The Journal of Rheumatology|December 17, 2015
Effectiveness of an Integrated Multidisciplinary Osteoarthritis Outpatient Program versus Outpatient Clinic as Usual: A Randomized Controlled TrialRikke Helene Moe, Margreth Grotle, Ingvild Kjeken, et al.
The Journal of Rheumatology|February 3, 2015
Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional studyInger Jorid Berg, Désirée van der Heijde, Hanne Dagfinrud, et al.
Trials|June 7, 2020
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trialMagnus Nakrem Lyngbakken, Jan-Erik Berdal, Arne Eskesen, et al.
Annals of the Rheumatic Diseases|November 29, 2013
Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010Anna-Birgitte Aga, Elisabeth Lie, Till Uhlig, et al.
Annals of the Rheumatic Diseases|June 24, 2018
Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomesNina Paulshus Sundlisæter, Anna-Birgitte Aga, Inge Christoffer Olsen, et al.
Nature Communications|October 21, 2020
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kineticsMagnus Nakrem Lyngbakken, Jan-Erik Berdal, Arne Eskesen, et al.
JAMA Network Open|April 2, 2026
Barriers and Facilitators of Platform TrialsStuart McLennan, Alexandra Griessbach, Sharon Love, et al.
The Lancet. Neurology|May 5, 2009
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trialPer Soelberg Sorensen, Svein Ivar Mellgren, Anders Svenningsson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2023
Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized TrialHåvard Midgard, Kristian Braathen Malme, Charlotte Meinich Pihl, et al.
Pageof 5